HCPCS Index Logo

HCPCS Codes Alphabetical Index

— Q —  /  — Q5 —

Q5001 — Hospice or home health care provided in patient's home/residence
Code added date: 20070101
Code effective date: 20130701
Q5001 in HTML format HTML  |  Q5001 in PDF (Portable Document Format) PDF  |  Q5001 in plain Text format TXT
Q5002 — Hospice or home health care provided in assisted living facility
Code added date: 20070101
Code effective date: 20130701
Q5002 in HTML format HTML  |  Q5002 in PDF (Portable Document Format) PDF  |  Q5002 in plain Text format TXT
Q5004 — Hospice care provided in skilled nursing facility (snf)
Code added date: 20070101
Code effective date: 20070101
Q5004 in HTML format HTML  |  Q5004 in PDF (Portable Document Format) PDF  |  Q5004 in plain Text format TXT
Q5005 — Hospice care provided in inpatient hospital
Code added date: 20070101
Code effective date: 20070101
Q5005 in HTML format HTML  |  Q5005 in PDF (Portable Document Format) PDF  |  Q5005 in plain Text format TXT
Q5006 — Hospice care provided in inpatient hospice facility
Code added date: 20070101
Code effective date: 20070101
Q5006 in HTML format HTML  |  Q5006 in PDF (Portable Document Format) PDF  |  Q5006 in plain Text format TXT
Q5007 — Hospice care provided in long term care facility
Code added date: 20070101
Code effective date: 20070101
Q5007 in HTML format HTML  |  Q5007 in PDF (Portable Document Format) PDF  |  Q5007 in plain Text format TXT
Q5008 — Hospice care provided in inpatient psychiatric facility
Code added date: 20070101
Code effective date: 20070101
Q5008 in HTML format HTML  |  Q5008 in PDF (Portable Document Format) PDF  |  Q5008 in plain Text format TXT
Q5009 — Hospice or home health care provided in place not otherwise specified (nos)
Code added date: 20070101
Code effective date: 20130701
Q5009 in HTML format HTML  |  Q5009 in PDF (Portable Document Format) PDF  |  Q5009 in plain Text format TXT
Q5010 — Hospice home care provided in a hospice facility
Code added date: 20101001
Code effective date: 20101001
Q5010 in HTML format HTML  |  Q5010 in PDF (Portable Document Format) PDF  |  Q5010 in plain Text format TXT
Q5098 — Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
Code added date: 20250701
Code effective date: 20250701
Q5098 in HTML format HTML  |  Q5098 in PDF (Portable Document Format) PDF  |  Q5098 in plain Text format TXT
Q5099 — Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
Code added date: 20250701
Code effective date: 20250701
Q5099 in HTML format HTML  |  Q5099 in PDF (Portable Document Format) PDF  |  Q5099 in plain Text format TXT
Q5100 — Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg
Code added date: 20250701
Code effective date: 20250701
Q5100 in HTML format HTML  |  Q5100 in PDF (Portable Document Format) PDF  |  Q5100 in plain Text format TXT
Q5101 — Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
Code added date: 20150701
Code effective date: 20240101
Q5101 in HTML format HTML  |  Q5101 in PDF (Portable Document Format) PDF  |  Q5101 in plain Text format TXT
Q5102 — Injection, infliximab, biosimilar, 10 mg
Code added date: 20160701
Code effective date: 20180401
Q5102 in HTML format HTML  |  Q5102 in PDF (Portable Document Format) PDF  |  Q5102 in plain Text format TXT
Q5103 — Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
Code added date: 20180401
Code effective date: 20180401
Q5103 in HTML format HTML  |  Q5103 in PDF (Portable Document Format) PDF  |  Q5103 in plain Text format TXT
Q5104 — Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
Code added date: 20180401
Code effective date: 20180401
Q5104 in HTML format HTML  |  Q5104 in PDF (Portable Document Format) PDF  |  Q5104 in plain Text format TXT
Q5106 — Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
Code added date: 20180701
Code effective date: 20200101
Q5106 in HTML format HTML  |  Q5106 in PDF (Portable Document Format) PDF  |  Q5106 in plain Text format TXT
Q5107 — Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
Code added date: 20190101
Code effective date: 20190101
Q5107 in HTML format HTML  |  Q5107 in PDF (Portable Document Format) PDF  |  Q5107 in plain Text format TXT
Q5108 — Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
Code added date: 20181001
Code effective date: 20230401
Q5108 in HTML format HTML  |  Q5108 in PDF (Portable Document Format) PDF  |  Q5108 in plain Text format TXT
Q5109 — Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
Code added date: 20190101
Code effective date: 20190101
Q5109 in HTML format HTML  |  Q5109 in PDF (Portable Document Format) PDF  |  Q5109 in plain Text format TXT
Q5110 — Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
Code added date: 20181001
Code effective date: 20181001
Q5110 in HTML format HTML  |  Q5110 in PDF (Portable Document Format) PDF  |  Q5110 in plain Text format TXT
Q5111 — Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
Code added date: 20190101
Code effective date: 20230401
Q5111 in HTML format HTML  |  Q5111 in PDF (Portable Document Format) PDF  |  Q5111 in plain Text format TXT
Q5112 — Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
Code added date: 20190701
Code effective date: 20231001
Q5112 in HTML format HTML  |  Q5112 in PDF (Portable Document Format) PDF  |  Q5112 in plain Text format TXT
Q5113 — Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
Code added date: 20190701
Code effective date: 20231001
Q5113 in HTML format HTML  |  Q5113 in PDF (Portable Document Format) PDF  |  Q5113 in plain Text format TXT
Q5114 — Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
Code added date: 20190701
Code effective date: 20190701
Q5114 in HTML format HTML  |  Q5114 in PDF (Portable Document Format) PDF  |  Q5114 in plain Text format TXT
Q5115 — Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
Code added date: 20190701
Code effective date: 20190701
Q5115 in HTML format HTML  |  Q5115 in PDF (Portable Document Format) PDF  |  Q5115 in plain Text format TXT
Q5116 — Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
Code added date: 20191001
Code effective date: 20191001
Q5116 in HTML format HTML  |  Q5116 in PDF (Portable Document Format) PDF  |  Q5116 in plain Text format TXT
Q5117 — Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
Code added date: 20191001
Code effective date: 20191001
Q5117 in HTML format HTML  |  Q5117 in PDF (Portable Document Format) PDF  |  Q5117 in plain Text format TXT
Q5118 — Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
Code added date: 20191001
Code effective date: 20191001
Q5118 in HTML format HTML  |  Q5118 in PDF (Portable Document Format) PDF  |  Q5118 in plain Text format TXT
Q5119 — Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
Code added date: 20200701
Code effective date: 20200701
Q5119 in HTML format HTML  |  Q5119 in PDF (Portable Document Format) PDF  |  Q5119 in plain Text format TXT
Q5120 — Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
Code added date: 20200701
Code effective date: 20230401
Q5120 in HTML format HTML  |  Q5120 in PDF (Portable Document Format) PDF  |  Q5120 in plain Text format TXT
Q5121 — Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
Code added date: 20200701
Code effective date: 20231001
Q5121 in HTML format HTML  |  Q5121 in PDF (Portable Document Format) PDF  |  Q5121 in plain Text format TXT
Q5122 — Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
Code added date: 20210101
Code effective date: 20230401
Q5122 in HTML format HTML  |  Q5122 in PDF (Portable Document Format) PDF  |  Q5122 in plain Text format TXT
Q5123 — Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
Code added date: 20210701
Code effective date: 20210701
Q5123 in HTML format HTML  |  Q5123 in PDF (Portable Document Format) PDF  |  Q5123 in plain Text format TXT
Q5124 — Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
Code added date: 20220401
Code effective date: 20230101
Q5124 in HTML format HTML  |  Q5124 in PDF (Portable Document Format) PDF  |  Q5124 in plain Text format TXT
Q5125 — Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Code added date: 20221001
Code effective date: 20221001
Q5125 in HTML format HTML  |  Q5125 in PDF (Portable Document Format) PDF  |  Q5125 in plain Text format TXT
Q5126 — Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Code added date: 20230101
Code effective date: 20230101
Q5126 in HTML format HTML  |  Q5126 in PDF (Portable Document Format) PDF  |  Q5126 in plain Text format TXT
Q5127 — Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
Code added date: 20230401
Code effective date: 20230401
Q5127 in HTML format HTML  |  Q5127 in PDF (Portable Document Format) PDF  |  Q5127 in plain Text format TXT
Q5128 — Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
Code added date: 20230401
Code effective date: 20230401
Q5128 in HTML format HTML  |  Q5128 in PDF (Portable Document Format) PDF  |  Q5128 in plain Text format TXT
Q5129 — Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
Code added date: 20230401
Code effective date: 20230701
Q5129 in HTML format HTML  |  Q5129 in PDF (Portable Document Format) PDF  |  Q5129 in plain Text format TXT
Q5130 — Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
Code added date: 20230401
Code effective date: 20230401
Q5130 in HTML format HTML  |  Q5130 in PDF (Portable Document Format) PDF  |  Q5130 in plain Text format TXT
Q5131 — Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
Code added date: 20230701
Code effective date: 20250101
Q5131 in HTML format HTML  |  Q5131 in PDF (Portable Document Format) PDF  |  Q5131 in plain Text format TXT
Q5132 — Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg
Code added date: 20240101
Code effective date: 20250101
Q5132 in HTML format HTML  |  Q5132 in PDF (Portable Document Format) PDF  |  Q5132 in plain Text format TXT
Q5133 — Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
Code added date: 20240401
Code effective date: 20241001
Q5133 in HTML format HTML  |  Q5133 in PDF (Portable Document Format) PDF  |  Q5133 in plain Text format TXT
Q5134 — Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
Code added date: 20240401
Code effective date: 20240401
Q5134 in HTML format HTML  |  Q5134 in PDF (Portable Document Format) PDF  |  Q5134 in plain Text format TXT
Q5135 — Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg
Code added date: 20241001
Code effective date: 20241001
Q5135 in HTML format HTML  |  Q5135 in PDF (Portable Document Format) PDF  |  Q5135 in plain Text format TXT
Q5136 — Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
Code added date: 20241001
Code effective date: 20241001
Q5136 in HTML format HTML  |  Q5136 in PDF (Portable Document Format) PDF  |  Q5136 in plain Text format TXT
Q5137 — Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg
Code added date: 20240701
Code effective date: 20240701
Q5137 in HTML format HTML  |  Q5137 in PDF (Portable Document Format) PDF  |  Q5137 in plain Text format TXT
Q5138 — Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg
Code added date: 20240701
Code effective date: 20240701
Q5138 in HTML format HTML  |  Q5138 in PDF (Portable Document Format) PDF  |  Q5138 in plain Text format TXT
Q5139 — Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg
Code added date: 20250101
Code effective date: 20250401
Q5139 in HTML format HTML  |  Q5139 in PDF (Portable Document Format) PDF  |  Q5139 in plain Text format TXT
Q5140 — Injection, adalimumab-fkjp, biosimilar, 1 mg
Code added date: 20250101
Code effective date: 20250101
Q5140 in HTML format HTML  |  Q5140 in PDF (Portable Document Format) PDF  |  Q5140 in plain Text format TXT
Q5141 — Injection, adalimumab-aaty, biosimilar, 1 mg
Code added date: 20250101
Code effective date: 20250101
Q5141 in HTML format HTML  |  Q5141 in PDF (Portable Document Format) PDF  |  Q5141 in plain Text format TXT
Q5142 — Injection, adalimumab-ryvk biosimilar, 1 mg
Code added date: 20250101
Code effective date: 20250101
Q5142 in HTML format HTML  |  Q5142 in PDF (Portable Document Format) PDF  |  Q5142 in plain Text format TXT
Q5143 — Injection, adalimumab-adbm, biosimilar, 1 mg
Code added date: 20250101
Code effective date: 20250101
Q5143 in HTML format HTML  |  Q5143 in PDF (Portable Document Format) PDF  |  Q5143 in plain Text format TXT
Q5144 — Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
Code added date: 20250101
Code effective date: 20250101
Q5144 in HTML format HTML  |  Q5144 in PDF (Portable Document Format) PDF  |  Q5144 in plain Text format TXT
Q5145 — Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
Code added date: 20250101
Code effective date: 20250101
Q5145 in HTML format HTML  |  Q5145 in PDF (Portable Document Format) PDF  |  Q5145 in plain Text format TXT
Q5146 — Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
Code added date: 20250101
Code effective date: 20250101
Q5146 in HTML format HTML  |  Q5146 in PDF (Portable Document Format) PDF  |  Q5146 in plain Text format TXT
Q5147 — Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg
Code added date: 20250401
Code effective date: 20250401
Q5147 in HTML format HTML  |  Q5147 in PDF (Portable Document Format) PDF  |  Q5147 in plain Text format TXT
Q5148 — Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
Code added date: 20250401
Code effective date: 20250401
Q5148 in HTML format HTML  |  Q5148 in PDF (Portable Document Format) PDF  |  Q5148 in plain Text format TXT
Q5149 — Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
Code added date: 20250401
Code effective date: 20250401
Q5149 in HTML format HTML  |  Q5149 in PDF (Portable Document Format) PDF  |  Q5149 in plain Text format TXT
Q5150 — Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
Code added date: 20250401
Code effective date: 20250401
Q5150 in HTML format HTML  |  Q5150 in PDF (Portable Document Format) PDF  |  Q5150 in plain Text format TXT
Q5151 — Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
Code added date: 20250401
Code effective date: 20250401
Q5151 in HTML format HTML  |  Q5151 in PDF (Portable Document Format) PDF  |  Q5151 in plain Text format TXT
Q5152 — Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg
Code added date: 20250401
Code effective date: 20250701
Q5152 in HTML format HTML  |  Q5152 in PDF (Portable Document Format) PDF  |  Q5152 in plain Text format TXT
Q5153 — Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg
Code added date: 20250701
Code effective date: 20250701
Q5153 in HTML format HTML  |  Q5153 in PDF (Portable Document Format) PDF  |  Q5153 in plain Text format TXT
Q5154 — Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
Code added date: 20251001
Code effective date: 20251001
Q5154 in HTML format HTML  |  Q5154 in PDF (Portable Document Format) PDF  |  Q5154 in plain Text format TXT
Q5155 — Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
Code added date: 20251001
Code effective date: 20251001
Q5155 in HTML format HTML  |  Q5155 in PDF (Portable Document Format) PDF  |  Q5155 in plain Text format TXT
Q5156 — Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
Code added date: 20251001
Code effective date: 20251001
Q5156 in HTML format HTML  |  Q5156 in PDF (Portable Document Format) PDF  |  Q5156 in plain Text format TXT
Q5157 — Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
Code added date: 20251001
Code effective date: 20251001
Q5157 in HTML format HTML  |  Q5157 in PDF (Portable Document Format) PDF  |  Q5157 in plain Text format TXT
Q5158 — Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
Code added date: 20251001
Code effective date: 20251001
Q5158 in HTML format HTML  |  Q5158 in PDF (Portable Document Format) PDF  |  Q5158 in plain Text format TXT
Q5159 — Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
Code added date: 20251001
Code effective date: 20251001
Q5159 in HTML format HTML  |  Q5159 in PDF (Portable Document Format) PDF  |  Q5159 in plain Text format TXT